We provide you with 20 years of free, institutional-grade data for BLUE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BLUE. Explore the full financial landscape of BLUE stock.
| Reported Date | CIK | Ticker | Type |
|---|
bluebird bio, Inc(NASDAQ:BLUE) 
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; Len...
Website: http://www.bluebirdbio.com
Founded: 1992
Full Time Employees: 1,171
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about BLUE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.